This clinical trial studies colposcopy and high resolution anoscopy in screening for anal dysplasia in patients with cervical, vaginal, or vulvar dysplasia or cancer. Screening may help doctors find cancer cells early and plan better treatment for cancer
OBJECTIVES: I. To evaluate the risk of anal dysplasia in women with cervical or vulvar dysplasia. OUTLINE: Patients undergo colposcopy and cervical Papanicolaou test with Human papillomavirus (HPV) test followed by anal Papanicolaou test and high resolution anoscopy. Patients with dysplastic anal lesions undergo repeat anoscopy at 3, 9, 15, and 24 months. Patients with normal anoscopy are followed up at 1 and 2 years.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SCREENING
Masking
NONE
Undergo colposcopy
Undergo cervical Pap smear
Undergo anal Pap smear
Undergo high resolution anoscopy
Risk of anal dysplasia in women with cervical or vulvar dysplasia
Time frame: Over 2 years
HPV (Human Papillomavirus) status
Time frame: Over 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.